AU2012200101B2 - A mixture for transdermal delivery of low and high molecular weight compounds - Google Patents

A mixture for transdermal delivery of low and high molecular weight compounds

Info

Publication number
AU2012200101B2
AU2012200101B2 AU2012200101A AU2012200101A AU2012200101B2 AU 2012200101 B2 AU2012200101 B2 AU 2012200101B2 AU 2012200101 A AU2012200101 A AU 2012200101A AU 2012200101 A AU2012200101 A AU 2012200101A AU 2012200101 B2 AU2012200101 B2 AU 2012200101B2
Authority
AU
Australia
Prior art keywords
mixture
low
molecular weight
high molecular
transdermal delivery
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2012200101A
Other versions
AU2012200101A1 (en
Inventor
Frederick L. Jordan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JRX Biotechnology Inc
Original Assignee
JRX Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2004283067A external-priority patent/AU2004283067A1/en
Application filed by JRX Biotechnology Inc filed Critical JRX Biotechnology Inc
Priority to AU2012200101A priority Critical patent/AU2012200101B2/en
Publication of AU2012200101A1 publication Critical patent/AU2012200101A1/en
Application granted granted Critical
Publication of AU2012200101B2 publication Critical patent/AU2012200101B2/en
Assigned to JRX BIOTECHNOLOGY, INC. reassignment JRX BIOTECHNOLOGY, INC. Request to Amend Deed and Register Assignors: ORYXE
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

AU2012200101A 2003-10-10 2012-01-06 A mixture for transdermal delivery of low and high molecular weight compounds Expired AU2012200101B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2012200101A AU2012200101B2 (en) 2003-10-10 2012-01-06 A mixture for transdermal delivery of low and high molecular weight compounds

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US60/510,615 2003-10-10
AU2004283067A AU2004283067A1 (en) 2003-10-10 2004-05-28 Transdermal high and low molecular weight compounds
AU2012200101A AU2012200101B2 (en) 2003-10-10 2012-01-06 A mixture for transdermal delivery of low and high molecular weight compounds

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
AU2004283067A Division AU2004283067A1 (en) 2003-10-10 2004-05-28 Transdermal high and low molecular weight compounds

Publications (2)

Publication Number Publication Date
AU2012200101A1 AU2012200101A1 (en) 2012-02-02
AU2012200101B2 true AU2012200101B2 (en) 2013-12-12

Family

ID=

Similar Documents

Publication Publication Date Title
HK1222789A1 (en) A mixture for transdermal delivery of low& and high molecular weight compounds
AU2003221770A1 (en) Controlled release transdermal drug delivery
AU2003302603A1 (en) Improved opioid pharmaceutical compositions
AU2003268087A1 (en) Liposomal gemcitabine compositions for better drug delivery
AU2003299849A1 (en) Drug delivery apparatus
AU2003245757A1 (en) Vaporizer delivery ampoule
AU2003299034A1 (en) Transdermal compositions
AU2003276656A1 (en) Transdermal delivery system for anti-emetic medication
AU2003222067A1 (en) System for delivery of therapeutic substances
AU2003210477A1 (en) Liposome drug delivery of polycyclic, aromatic, antioxidant or anti-inflammatory compounds
PL1765310T3 (en) A mixture for transdermal delivery of low and high molecular weight compounds
AU2003245504A1 (en) Pharmaceutical compositions for drugs having ph-dependentsolubility
AU2003212962A1 (en) Transdermal drug delivery systems
AU2003205570A1 (en) Combination of mtp inhibitors or apob secretion inhibitors with fibrates for use as drugs
EP1684681A4 (en) Transdermal high and low molecular weight compounds
AU2003241134A1 (en) Transdermal drug delivery system
AU2003207461A1 (en) Drug mixture with enhanced dissolution rate
AU2003272127A1 (en) Polymeric composition for drug delivery
AU2012200101B2 (en) A mixture for transdermal delivery of low and high molecular weight compounds
AU2003900586A0 (en) Delivery of metered doses
AU2002308649A1 (en) Compositions and methods for enhancing drug delivery
AU2003252337A1 (en) Patch for transdermal administration
AU2003237894A1 (en) Liposome drug delivery
AU2003235931A1 (en) Vintoperol-containing medicinal composition for transdermal administration
AU2003291458A1 (en) Pharmaceutical compositions and methods of using taxane derivatives